Auris Medical Holding Ltd. Prices $8,000,000 Common Shares Offering Priced At-the-Market
Hamilton, Bermuda, December 2, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS) (“Auris” or the “Company”), a clinical-stage company dedicated...
Hamilton, Bermuda, December 2, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS) (“Auris” or the “Company”), a clinical-stage company dedicated...
Alliance with Texas-Based Dental Support Organization Increases SmileDirectClub Partner Network Footprint in Lone Star State Over 1,000+ Affiliated Practices Across the...
Appointment strengthens leadership team ahead of tebipenem HBr’s potential commercializationCAMBRIDGE, Mass., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:...
Webinar Scheduled for 11:00 AM PT/2:00 PM ETSOUTH SAN FRANCISCO, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc....
NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software...
WOBURN, Mass., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that Meghna...
LA JOLLA, Calif., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the...
Combined solutions streamline clinical access, heighten security, and protect patient privacy across the healthcare continuumLEXINGTON, Mass., Dec. 02, 2020 (GLOBE...
MORRISVILLE, N.C., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only...
Boston, Dec. 02, 2020 (GLOBE NEWSWIRE) -- As part of its continuing efforts to help businesses plan for and manage...
TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 3- to 6-week radiotherapy, significantly reducing COVID-19 risk to patients amidst coming...
SPRING HOUSE, Pa., Dec. 02, 2020 (GLOBE NEWSWIRE) -- SteroTherapeutics, LLC, a biopharmaceutical company developing new treatments for patients with...
PITTSBURGH, Dec. 02, 2020 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company"), a biotechnology company accelerating...
Proceeds support expanded clinical program of BST-236, a proprietary anti-metabolite enabling high-dose chemotherapy with reduced systemic toxicityAIRPORT CITY, Israel, Dec. 02,...
Conference Call and Webcast Scheduled for December 9, 2020, 4:30 pm ET NEW YORK, NY, Dec. 02, 2020 (GLOBE NEWSWIRE)...
DUBLIN, Ireland, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization...
BUFFALO, N.Y., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery,...
Announces Insider Participation in the Private Placement Announces Registration Rights Agreement DENVER, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Assure Holdings...
Scheduled to Reconvene on December 30, 2020NEW YORK, Dec. 02, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven...
CAMBRIDGE, Mass., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...